Wearable Artificial Kidney Market Outlook - 2027
In end-stage of a kidney disease, the kidneys are not able to perform their functions such as filtering and eliminating of blood wastes and other fluids. Majority of the people suffering from end-stage kidney disease have to depend on dialysis treatment. Though dialysis eliminates fluids and metabolic wastes, it cannot compensate the lost kidney functions such as regulating metabolism, endocrine function, and homeostasis. As a result, the wearable artificial kidney as an alternative to dialysis treatment can help patients as it does not require any artificial kidney-related tethers or external tubes and is powered by blood pressure of the body. This device provides individuals an anywhere and anytime dialysis. The device is worn on the body of the patients in order to offer renal replacement. It also minimizes the patient visits to hospitals for dialysis treatment.
The wearable artificial kidney contains a hemofilter that filters the incoming blood containing toxins along with sugars and salts. A bioreactor present in this artificial kidney processes the filtrate and segregates salts and sugars and sends them into the blood stream again. Simultaneously, water is also absorbed and the concentrated filtrate carrying metabolic wastes is directed to urinary bladder for excretion.
COVID – 19 scenario analysis:
- Due to the COVID – 19 outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus.
- R&D labs are also focusing on finding a breakthrough vaccine against Novel coronavirus
- In addition, the medical professionals are engaged in providing COVID-19 related services, unavailability if experts to conduct cardiac mapping.
- As a result, other healthcare segments have to face negligence.
- The U.S. Centers for Disease Control (CDC) issued some guidelines recently suggesting dialysis patients to minimize their visits if not urgent and dialysis centers to help them identify and handle suspected cases and to minimize exposure to other patients
- Patients with kidney ailments are also asked to take extra precautions as transplant recipients takes immunosuppressive drugs, they are at higher risk of infection from viruses such as cold or flu.
- Some ongoing research have also suggested that people with kidney disorders are more prone to get infected by SARS-CoV-2
- As a result, these creates optimum conditions for the wearable artificial kidney market to flourish due to fear pertaining ongoing pandemic.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The increasing geriatric population and growth in kidney disorders are other major prominent drivers of diuretic drugs market. Chronic Kidney Disease (CKD) being one of the prominent factor causing kidney failure in patients. The National Kidney Foundation (NKD), highlighted around 10% of the population worldwide is prone to CKD and causes millions of fatalities due to this condition annually. As per NKD studies, aging population especially in developing economies like India and China, is affected due to renal ailments.
Rise in technological developments and innovations in artificial kidney devices and related field has further surged the demand. The U.S. FDA in Feb 2014, gave approval to premier human clinical trials for Blood Purification Technologies in order to develop Wearable Artificial Kidney (WAK) 2.0. This innovative solution aims to increase efficacy and satisfactory outcomes in the patients.
Furthermore, the rising awareness about various kidney-related disorders and associated treatment, unhealthy lifestyle, and growing health concerns are among the other factors fueling the market growth. The National Institutes of Health (NIH) recognizes March as National Kidney Month aiming to increase awareness regarding CKD and renal failure. As a result, initiatives and awareness campaigns to educate people about CKD and kidney failures along with encouraging patients to opt for dialysis with the help of wearable artificial kidney will have a positive impact on wearable artificial kidney market.
On the contrary, lack of awareness regarding the wearable artificial kidney in under developed economies will hamper the growth of the wearable artificial kidney market.
Rising prevalence of kidney disorders to boost the market growth
Rising incidences of kidney disorders are causing high expenditures on healthcare due to high cost of treatment, thus paving a way for growth on wearable artificial kidney market. The increase in the renal and kidney disorder cases causing a tremendous rise in patients suffering from these disease to drives the global wearable artificial kidney market. The Centers for Disease Control and Prevention (CDC), in 2019 estimated that over 37 million people were affected due to chronic kidney disease. The increasing prevalence of kidney disorders is majorly due to sedentary lifestyle, high consumption of fast food and packaged food with high levels of calcium and other minerals. As per the Global Burden Disease 2015 study, approximately 1.2 million people died due to kidney failure, which denotes a significant 32% rise since 2005. The population majorly affected by kidney disorders belongs to age group above 60 years. A recently published news states that end-stage renal disease is observed in approximately 2 million people and the number of patients detected with kidney-related disorders continues grow at a rate of 5%-7% annually.
North American segment to have dominance in the market with highest market share
North America is expected to have significant growth in the market and holds the highest market share in the regional segments. The dominance is due to factors like growing prevalence of end stage kidney disease higher adoption of technology in the region resulting for higher demand for innovative management technologies is propelling the market in the United States. As per the Centers for Disease Control and Prevention, the U.S. adults aged 18 years or above diagnosed with high blood pressure and diabetes were the patients suffering with end stage kidney disease. Furthermore, drastic rise in healthcare expenditure and high strain to achieve better health outputs at lower costs, availability of a well-developed infrastructure, and presence of major industry players are the other factors fostering the market growth in the near future.
Key benefits of the report:
- This study presents the analytical depiction of the global wearable artificial kidney market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global wearable artificial kidney market share.
- The current market is quantitatively analyzed to highlight the global wearable artificial kidney market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Wearable artificial kidney Market research report:
- What are the leading market players active in the wearable artificial kidney market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Wearable Artificial Kidney Market, by Disease Stage Report Highlights
| Aspects | Details |
 By Disease Stage |
|
 By Dialysis Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Kawasumi Laboratories Inc, Dutch Kidney Foundation., Asahi Kasei Medical Vo., Ltd, Triomed AB, International Renal Research Institute of Vicenza, San Bortolo Hospital, Blood Purification Technologies Inc, Nanodialysis BV, AWAK Technologies Pte. Ltd. |
 Other Players | Stryker Corporation, Inc |
Loading Table Of Content...
